IBU — Class III drug recall D-0047-2025
Ongoing recall by Dr. Reddy's Laboratories, Inc., reported 2024-11-27, distributed nationwide. Failed Tablet/Capsule Specifications
| Recall number | D-0047-2025 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Dr. Reddy's Laboratories, Inc., Princeton, NJ, United States |
| Recall initiated | 2024-10-29 |
| Classified | 2024-11-15 |
| Reported by FDA | 2024-11-27 |
| Distributed | Nationwide (US) |
| Quantity | 3,416 botttles |
| NDC | 55111-0682, 55111-0682-01, 55111-0682-05, 55111-0682-09, 55111-0683, 55111-0683-01, 55111-0683-05, 55111-0683-09, 55111-0683-30, 55111-0683-50, 55111-0684, 55111-0684-01, 55111-0684-05, 55111-0684-09, 55111-0684-30, 55111-0684-50, 55111-0684-60 |
| Lot numbers | C5406201 |
| Expiration dates | 2028-03-31 |
Product
IBU (ibuprofen) 600 mg tablets, 500-count bottle, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 55111-683-05
Reason for recall
Failed Tablet/Capsule Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0047-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.